UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

South Atlantic Bancshares, Inc. (SABK) shares rallied 9.1% in the last trading session to close at $15.98. This move can be attributable to notable volume with a higher number of shares being traded ...

Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...

Two Sigma Investments LP purchased a new position in United Community Banks, Inc. (NASDAQ:UCB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 8,708 shares of the ...

The drug is closely related to UCB's existing Keppra, but mouse studies suggested it was 10 times more potent in preventing certain types of seizures. If it can replicate this profile in phase III ...

Belgian drugmaker UCB (Euronext: UCB) today announced new three-year data from Phase III trials, and their open-label ...

United Community Banks (UCB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

HS is estimated to affect about 1% of the adult population, per UCB, and can cause severe pain and flare-ups that include nodules, abscesses and pus-discharging fistulas in areas like the armpits ...

Ultimately, UCB sought to shift the campaign’s content towards more collaborative, patient-centered health communication, which can also inform HCPs of how to address their patients’ concerns. From ...

You can reach Adam on Signal at stataf.54. Biogen and UCB said Tuesday that an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal of a placebo ...

UCB emerged as a major biopharmaceutical player ... This dynamic supports a fragmented market, where many therapies can see strong share gains despite competition. However, many efficacious ...